在卵胺诱导喘模型中,2-基缩减了气道炎症,氧化应激和NF-κB激活
Islam Ahmed Abdelmawgood1, Mohamed A Kotb1, Bassam Waleed Ebeed1
1Zoology Department, Faculty of Science, Cairo University, 12613, Giza, Egypt.
概括
通过降低炎症和氧化应激,2-二 (2HC) 有效地减少了小鼠的喘症状. 这表明2HC可能是治疗过敏喘的潜在治疗剂.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是一种慢性呼吸道疾病,其特点是气道炎症和过度反应.
- 果是黄类的前体,具有多种生物活性,包括抗炎和抗氧化特性.
- 2-二 (2HC) 已在各种生物功能中表现出潜力,但其在喘治疗中的作用仍然未被探索.
研究的目的:
- 为了研究2-Hydroxychalcone (2HC) 作为过敏性喘治疗剂的潜力.
- 评估2HC对关键喘相关炎症通路和标记物的抑制作用.
主要方法:
- 在这项研究中使用了一种卵泡胺 (OVA) 诱导的喘小鼠模型.
- 评估了2HC给药对呼吸道炎症,炎症细胞透,氧化应激,粘液产生,IgE,IL-4,IL-1β和NF-κB表达的影响.
- 定量分析包括ELISA和免疫组织化学 (IHC) 用于NF-κB量化.
主要成果:
- 在喘模型中,2HC的使用显著降低了肺氧化应激和炎症细胞透.
- 在2HC治疗后,免疫球蛋白E (IgE),IL-4,IL-1β和粘液生产的水平显著下降.
- 关键的炎症媒介NF-κB的激活被2HC显著抑制.
结论:
- 2-基甲具有与喘相关的显著抗炎和抗氧化特性.
- 这些发现表明,通过抑制NF-κB激活,2HC可能是喘管理的有希望的治疗候选者.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:20Asthma: Pathogenesis and Management
613
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
613
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
476
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
476
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
470
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
470
01:19Antiasthma Drugs: Leukotriene Modifiers
495
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
495